Sangamo Therapeutics
(SGMO)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -95,419 | -68,889 | -54,568 | -71,658 | -40,703 |
| Depreciation Amortization | 4,899 | -3,470 | 825 | 1,218 | 1,815 |
| Accounts receivable | -32,543 | -1,465 | 1,613 | -2,061 | 7,963 |
| Other Working Capital | -73,010 | 93,266 | 55,741 | -10,585 | -910 |
| Other Operating Activity | 51,671 | 17,108 | 7,568 | 17,203 | -1,885 |
| Operating Cash Flow | $-144,402 | $36,550 | $11,179 | $-65,883 | $-33,720 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -38,864 | -59,394 | -73,653 | 18,857 | 79,873 |
| PPE Investments | -20,675 | -43,065 | -3,751 | -732 | N/A |
| Net Acquisitions | N/A | -75,647 | N/A | N/A | -2,411 |
| Purchase Of Investment | -262 | N/A | N/A | N/A | N/A |
| Investing Cash Flow | $-59,801 | $-178,106 | $-77,404 | $18,125 | $77,462 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 142,451 | 231,963 | 98,144 | 1,113 | 6,804 |
| Other Financing Activity | -422 | -254 | -654 | -776 | 12,906 |
| Financing Cash Flow | $142,029 | $231,709 | $97,490 | $337 | $19,710 |
| Exchange Rate Effect | 184 | 439 | N/A | N/A | N/A |
| Beginning Cash Position | 143,918 | 53,326 | 22,061 | 69,482 | 6,030 |
| End Cash Position | 81,928 | 143,918 | 53,326 | 22,061 | 69,482 |
| Net Cash Flow | $-61,990 | $90,592 | $31,265 | $-47,421 | $63,452 |
| Free Cash Flow | |||||
| Operating Cash Flow | -144,402 | 36,550 | 11,179 | -65,883 | -33,720 |
| Capital Expenditure | -20,675 | -43,065 | -3,751 | -732 | 0 |
| Free Cash Flow | -165,077 | -6,515 | 7,428 | -66,615 | -33,720 |